Nandakumar KS - Search Results

1

Recent Research on Flavonoids and their Biomedical Applications.

Wen K, Fang X, Yang J, Yao Y, Nandakumar KS, Salem ML, Cheng K. Wen K, et al. Among authors: nandakumar ks. Curr Med Chem. 2021;28(5):1042-1066. doi: 10.2174/0929867327666200713184138. Curr Med Chem. 2021. PMID: 32660393 Review.

2

Targeting pattern-recognition receptors to discover new small molecule immune modulators.

Zhu G, Xu Y, Cen X, Nandakumar KS, Liu S, Cheng K. Zhu G, et al. Among authors: nandakumar ks. Eur J Med Chem. 2018 Jan 20;144:82-92. doi: 10.1016/j.ejmech.2017.12.026. Epub 2017 Dec 8. Eur J Med Chem. 2018. PMID: 29268133 Review.

3

TLR1/2 Specific Small-Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes.

Cen X, Zhu G, Yang J, Yang J, Guo J, Jin J, Nandakumar KS, Yang W, Yin H, Liu S, Cheng K. Cen X, et al. Among authors: nandakumar ks. Adv Sci (Weinh). 2019 Mar 27;6(10):1802042. doi: 10.1002/advs.201802042. eCollection 2019 May 17. Adv Sci (Weinh). 2019. PMID: 31131189 Free PMC article.

4

Autophagy induced by STING, an unnoticed and primordial function of cGAS.

Yang J, Tang X, Nandakumar KS, Cheng K. Yang J, et al. Among authors: nandakumar ks. Cell Mol Immunol. 2019 Aug;16(8):683-684. doi: 10.1038/s41423-019-0240-2. Epub 2019 May 29. Cell Mol Immunol. 2019. PMID: 31142798 Free PMC article. No abstract available.

5

Potential treatment methods targeting 2019-nCoV infection.

Zheng L, Zhang L, Huang J, Nandakumar KS, Liu S, Cheng K. Zheng L, et al. Among authors: nandakumar ks. Eur J Med Chem. 2020 Nov 1;205:112687. doi: 10.1016/j.ejmech.2020.112687. Epub 2020 Jul 28. Eur J Med Chem. 2020. PMID: 32771797 Free PMC article. Review.

6

Design and pharmaceutical applications of proteolysis-targeting chimeric molecules.

Liang Y, Nandakumar KS, Cheng K. Liang Y, et al. Among authors: nandakumar ks. Biochem Pharmacol. 2020 Dec;182:114211. doi: 10.1016/j.bcp.2020.114211. Epub 2020 Aug 29. Biochem Pharmacol. 2020. PMID: 32866456 Review.

7

Design, Synthesis, and Structure-Activity Relationship of N-Aryl-N'-(thiophen-2-yl)thiourea Derivatives as Novel and Specific Human TLR1/2 Agonists for Potential Cancer Immunotherapy.

Chen Z, Zhang L, Yang J, Zheng L, Hu F, Duan S, Nandakumar KS, Liu S, Yin H, Cheng K. Chen Z, et al. Among authors: nandakumar ks. J Med Chem. 2021 Jun 10;64(11):7371-7389. doi: 10.1021/acs.jmedchem.0c02266. Epub 2021 May 24. J Med Chem. 2021. PMID: 34029463

8

Imidazole Scaffold Based Compounds in the Development of Therapeutic Drugs.

Hu F, Zhang L, Nandakumar KS, Cheng K. Hu F, et al. Among authors: nandakumar ks. Curr Top Med Chem. 2021;21(28):2514-2528. doi: 10.2174/1568026621666210527103225. Curr Top Med Chem. 2021. PMID: 34047259 Review.

9

Optimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches.

Zheng Y, Nandakumar KS, Cheng K. Zheng Y, et al. Among authors: nandakumar ks. J Med Chem. 2021 Jul 22;64(14):9577-9591. doi: 10.1021/acs.jmedchem.0c02054. Epub 2021 Jun 30. J Med Chem. 2021. PMID: 34191515 Review.

10

Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy.

Cen X, Wang B, Liang Y, Chen Y, Xiao Y, Du S, Nandakumar KS, Yin H, Liu S, Cheng K. Cen X, et al. Among authors: nandakumar ks. Acta Pharm Sin B. 2022 Sep;12(9):3667-3681. doi: 10.1016/j.apsb.2022.06.001. Epub 2022 Jun 9. Acta Pharm Sin B. 2022. PMID: 36176917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page